Reconsidering the Widespread Use of Active Vitamin D Analogues for Osteoporosis in Japan: A Call for Evidence-Based Prescription Practices
Abstract
In Japan, active vitamin D has been widely prescribed for osteoporosis due to its regulatory approval, in contrast to international practice where it is not considered standard therapy. However, growing evidence indicates that these agents offer limited efficacy in fracture prevention and may pose significant risks. Mechanistically, active vitamin D increases both serum calcium and phosphate, which, in the absence of bone-forming signals such as growth, fracture healing, or high mechanical loading, may promote ectopic calcification rather than bone strengthening. Osteoporosis, particularly in low-turnover states common in aging or immobilization, is poorly responsive to active vitamin D, as calcium incorporation into bone is physiologically limited. Clinical trials have shown little benefit of vitamin D supplementation in individuals without deficiency, and adverse outcomes such as hypercalcemia, nephrolithiasis, kidney impairment, and vascular calcification have been documented, including a recent case series in patients with severe motor and intellectual disabilities. Despite these concerns, Japanese guidelines continue to list active vitamin D as an effective option, diverging from the recommendations of the European Society for Clinical and Economic Aspects of Osteoporosis and the United States Endocrine Society, which reflect nuanced, evidence-graded recommendations rather than explicit discouragement in primary osteoporosis. The persistence of widespread prescribing in…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.